The estimated Net Worth of Jeanne K Mason is at least $12.3 Миллион dollars as of 1 March 2024. Ms. Mason owns over 64,488 units of Baxter International stock worth over $8,120,172 and over the last 19 years he sold BAX stock worth over $0. In addition, he makes $4,143,630 as Senior Vice President - Human Resources at Baxter International.
Sign up
Ms. Mason BAX stock SEC Form 4 insiders trading
Jeanne has made over 9 trades of the Baxter International stock since 2012, according to the Form 4 filled with the SEC. Most recently he exercised 64,488 units of BAX stock worth $2,397,019 on 1 March 2024.
The largest trade he's ever made was exercising 64,488 units of Baxter International stock on 1 March 2024 worth over $2,397,019. On average, Jeanne trades about 7,099 units every 78 days since 2006. As of 1 March 2024 he still owns at least 206,778 units of Baxter International stock.
You can see the complete history of Ms. Mason stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Jeanne Mason biography
Dr. Jeanne K. Mason Ph.D., is Senior Vice President - Human Resources of the Company. Ms. Mason joined Baxter in 2006 from GE Insurance Solutions, a primary insurance and reinsurance business, where she was responsible for global human resource functions. Ms. Mason began her career with General Electric (GE) in 1988 after serving with the U.S. General Accounting Office in Washington, D.C. Her GE experience included leadership roles in Europe for GE Information Services and GE Capital Real Estate. She is a member of the Board of Directors of Family Service of Lake County and is a member of the Executive Advisory Council for the Chicago Chapter of National Association of African Americans in Human Resources.
What is the salary of Jeanne Mason?
As the Senior Vice President - Human Resources of Baxter International, the total compensation of Jeanne Mason at Baxter International is $4,143,630. There are 2 executives at Baxter International getting paid more, with Jose Almeida having the highest compensation of $13,913,800.
How old is Jeanne Mason?
Jeanne Mason is 64, he's been the Senior Vice President - Human Resources of Baxter International since 2017. There are 8 older and 21 younger executives at Baxter International. The oldest executive at Baxter International Inc. is James Gavin, 74, who is the Independent Director.
What's Jeanne Mason's mailing address?
Jeanne's mailing address filed with the SEC is ONE BAXTER PARKWAY, , DEERFIELD, IL, 60015.
Insiders trading at Baxter International
Over the last 22 years, insiders at Baxter International have traded over $966,809,165 worth of Baxter International stock and bought 178,227 units worth $6,261,495 . The most active insiders traders include Point Llc Loeb Daniel S Third, Michael F Mahoney и Jeffrey A Craig. On average, Baxter International executives and independent directors trade stock every 37 days with the average trade being worth of $3,609,738. The most recent stock trade was executed by Jeanne K Mason on 1 March 2024, trading 64,488 units of BAX stock currently worth $2,397,019.
What does Baxter International do?
baxter provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile iv solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software and services. the company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.
What does Baxter International's logo look like?
Complete history of Ms. Mason stock trades at Baxter International
Baxter International executives and stock owners
Baxter International executives and other stock owners filed with the SEC include:
-
Jose Almeida,
Chairman of the Board, President, Chief Executive Officer -
James Saccaro,
Chief Financial Officer, Executive Vice President -
Jeanne Mason,
Senior Vice President - Human Resources -
Giuseppe Accogli,
Senior Vice President, President- America -
Sean Martin,
Senior Vice President, General Counsel -
Cristiano Franzi,
Senior Vice President and President, EMEA -
Jose E. Almeida,
Chairman, Pres & CEO -
Cristiano Franzi,
Sr. VP & Pres for EMEA -
Giuseppe Accogli,
Exec. VP & COO -
James K. Saccaro,
Exec. VP & CFO -
Sean B. W. Martin,
Sr. VP & Gen. Counsel -
Thomas Stallkamp,
Lead Independent Director -
Albert Stroucken,
Independent Director -
Peter Hellman,
Independent Director -
James Gavin,
Independent Director -
Patricia Morrison,
Independent Director -
Stephen Oesterle,
Independent Director -
Amy Wendell,
Independent Director -
John Forsyth,
Independent Director -
Michael Mahoney,
Independent Director -
Cathy Smith,
Independent Director -
Thomas Chen,
Independent Director -
Jacqueline Kunzler,
Senior Vice President and Chief Quality Officer -
Andrew Frye,
Senior Vice President and President, APAC -
Brian Stevens,
Senior Vice President, Chief Accounting Officer, Controller -
David S. Rosenbloom,
Sr. VP & Gen. Counsel -
Clare Trachtman,
VP of Investor Relations -
Brian C. Stevens,
Sr. VP, Chief Accounting Officer & Controller -
Wilber C. Boren IV,
Pres of Advanced Surgery -
Andrew Frye,
Sr. VP & Pres of APAC -
Jeanne K. Mason,
Sr. VP of HR -
Stacey Eisen,
Sr. VP of Global Communications -
Talvis P. Love,
Sr. VP & Chief Information Officer -
David P. Scharf,
Corporate Vice President -
Kees J Storm,
Director -
Marcus Schabacker,
CVP, Chief Scientific Officer -
Robert Felicelli,
CVP, Quality -
Brik V Eyre,
CVP, Hospital Products -
Carole J Uhrich,
Director -
Paul Vibert,
CVP, International -
Scott Pleau,
CVP - Operations -
Caroline Karp,
CVP, Controller -
Point Llc Loeb Daniel S Third,
-
Christopher A. Toth,
EVP,Group Pres, Kidney Care -
William A. Ii Ampofo,
Director -
Steven Flynn,
SVP, President, APAC -
Peter M Wilver,
Director -
David Brent Shafer,
Director -
Thomas J Jr Sabatino,
Senior Vice President -
Yuan Chia Pei,
Director -
Cheryl L White,
Corporate Vice President -
Joy A Amundson,
Corporate Vice President -
Jill M Schaaf,
CVP, Renal -
Harry M Jansen Jr Kraemer,
Chairman and -
Robert J. Hombach,
Corporate Vice President & CFO -
James E Utts,
Corporate Vice President -
Uma Chowdhry,
Director -
Peter J Arduini,
Corporate Vice President -
Bruce Mc Gillivray,
Corporate Vice President -
Sebastian J Bufalino,
Corporate Vice President -
Jean Luc Butel,
Corporate Vice President -
James M Gatling,
Corporate Vice President -
John C Moon,
Corporate Vice President -
Salto Carlos Del,
Senior Vice President -
Wayne T Hockmeyer,
Director -
Joseph B Martin,
Director -
Michael J Baughman,
Corporate Vice President -
Steven J Meyer,
Treasurer -
Michael J Tucker,
Senior Vice President -
James R Hurley,
Corporate Vice President -
Monroe E Trout,
Director -
Thomas Fang Tyan Chen,
Director -
Nevelle J Jeharajah,
Corporate Vice President -
Robert M Davis,
Corp. VP, CFO and Treasurer -
Jan Stern Reed,
Corporate Secretary -
Thomas H Glanzmann,
Senior Vice President -
Walter E Boomer,
Director -
Gail D Fosler,
Director -
Phillip L. Batchelor,
Corporate Vice President -
Karenann K Terrell,
Corporate Vice President -
Robert L Jr Parkinson,
Chairman of the Board and -
Karen J May,
Corporate Vice President -
Timothy P Lawrence,
CVP, Operations -
Blake E Devitt,
Director -
John J Greisch,
Senior Vice President & CFO -
Munib Islam,
Director -
Gregory P Young,
Corporate Vice President -
Susan R Lichtenstein,
Corporate Vice President, -
Lawrence T Gibbons,
Corporate Vice President -
David F Drohan,
Senior Vice President -
Fred L Turner,
Director -
Norbert G Riedel,
Corporate Vice President -
Brian P Anderson,
Senior Vice President -
Ludwig Hantson,
Corporate Vice President -
David S. Wilkes,
Director -
Nancy M Schlichting,
Director -
Joel T. Grade,
EVP and CFO -
Alok Sonig,
EVP,Group President, Pharma -
David S. Rosenbloom,
EVP and General Counsel -
Heather Knight,
EVP,Group Pres,Med Products -
Reazur Rasul,
EVP,Group Pres, Healthcare -
Jeffrey A Craig,
Director -
Stephen H Rusckowski,
Director -
James W Borzi,
EVP,Chief Supply Chain Officer